Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 14 of 30.
Sep 2020
Aug 2020
7 Aug · Results
7 Aug · Board meeting
Jul 2020
30 Jul · Board meeting
20 Jul · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....
Shareholding for the Period Ended June 30, 202017 Jul · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 3 1 2
Statement Of Investor Complaints For The Quarter Ended June 202015 Jul · Legal
Exchange has sought clarification from Lyka Labs Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.8 Jul · Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, Please Find Enclosed Herewith The Disclosures Of Related Party Transaction On Consolidated Basis For The Half Year Ended On 31St March, 2020.
Jun 2020
15 Jun · Confirmation Regarding Non Applicability Of SEBI Circular Dated 26Th November, 2018.
10 Jun · Updates
10 Jun · Board Meeting Update
10 Jun · Results
10 Jun · Results
10 Jun · Board meeting
10 Jun · Board meeting
9 Jun · Material Disclosure In Terms Of Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015.- SEBI Order Dated 05Th June, 2020 In Respect Of GDR Issue.
5 Jun · Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosures Requirements), 2015 - Impact Of COVID-19
3 Jun · Board meeting
May 2020
Apr 2020
23 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015
20 Apr · Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Shareholding for the Period Ended March 31, 202011 Apr · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended March 20209 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For The Half Year Ended 31St March, 2020
8 Apr · With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the ....
Clarification8 Apr · Legal
Clarification sought from Lyka Labs Ltd7 Apr · Legal
The exchange asked on 7 Apr 2020
Mar 2020
Feb 2020
28 Feb · Meeting